Managed Care Cast

By Managed Care CastScience

Managed Care Cast episodes

February 04, 2019 This Week in Managed Care—Congressional Drug Price Hearings and Other Health News
Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included House and Senate hearings on the cost of prescription drugs; a study finding patients with diabetes can be safely switched to cheaper insulin; and the first non-chemotherapy combination being approved for the treatment of chronic lymphocytic leukemia.
Read more about the stories in this podcast:
Senate Committee Discusses the Burden of High Drug Prices and Potential Solutions: https://www.ajmc.com/newsroom/senate-committee-discusses-the-burden-of-high-drug-prices-and-potential-solutions
Medicare Patients With Type 2 Diabetes Safely Switched From Analog to Human Insulin, JAMA Study Finds: https://www.ajmc.com/newsroom/medicare-patients-with-type-2-diabetes-safely-switched-from-analog-to-human-insulin-ijamai-study-finds
FDA Approves Ibrutinib Combination as Frontline Treatment for CLL: https://www.ajmc.com/newsroom/fda-approves-ibrutinib-combination-as-frontline-treatment-for-cll
What Do Americans Think About Medicare for All? It Depends on What They Hear: https://www.ajmc.com/focus-of-the-week/what-do-americans-think-about-medicare-for-all-it-depends-on-what-they-hear
Congress Doubles Down on High Drug Prices, but Is It More Talk Than Action? https://www.ajmc.com/focus-of-the-week/congress-doubles-down-on-high-drug-prices-but-is-it-more-talk-than-action
The Drug Price Iceberg: More Than Meets the Eye: https://www.ajmc.com/journals/issue/2019/2019-vol25-n2/the-drug-price-iceberg-more-than-meets-the-eye
7 min
January 29, 2019 Discussing the Continuing Decline in Overall Cancer Mortality in the United States
Discussing the Continuing Decline in Overall Cancer Mortality in the United States by Managed Care Cast
13 min
January 26, 2019 This Week in Managed Care—Tracking Drug Price Hikes and Other Health News
Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included the Institute for Clinical and Economic Review investigating rising drug prices; CMS expanding value-based insurance design; and researchers using a blood test to detect preclinical Alzheimer disease.
Read more about the stories in this podcast:
What's Driving US Healthcare Costs? Stakeholders Weigh In: https://www.ajmc.com/focus-of-the-week/whats-driving-us-healthcare-costs-stakeholders-weigh-in
ICER Will Review If Drug Price Hikes Are Supported by New Evidence: https://www.ajmc.com/newsroom/icer-will-review-if-drug-price-hikes-are-supported-by-new-evidence
Report: Increasing Drug Prices, Shortages Causing Hospitals to Cut Staff, Putting Patient Safety at Risk: https://www.ajmc.com/focus-of-the-week/report-increasing-drug-prices-shortages-causing-hospitals-to-cut-staff-putting-patient-safety-at-risk
What We're Reading: Insulin Costs Double; PhRMA's Record Spending; Causes of Liver Transplants: https://www.ajmc.com/newsroom/what-were-reading-insulin-costs-double-phrmas-record-spending-causes-of-liver-transplants
CMS Expands VBID in Medicare Advantage, Increases Risk Sharing in Part D: https://www.ajmc.com/newsroom/cms-expands-vbid-in-medicare-advantage-increases-risk-sharing-in-part-d
Researchers Use Blood Test to Detect Preclinical Alzheimer Disease Signs: https://www.ajmc.com/newsroom/researchers-use-blood-test-to-detect-preclinical-alzheimer-disease-signs
Improving Care for Patients With Metastatic Breast Cancer: https://www.ajmc.com/peer-exchange/advances-metastatic-breast-cancer/improving-care-for-patients-with-metastatic-breast-cancer
6 min
January 22, 2019 As Cancer Incidence Changes, so Do Screening Recommendations
As Cancer Incidence Changes, so Do Screening Recommendations by Managed Care Cast
37 min
January 19, 2019 This Week in Managed Care—New Drug Pricing Probe and Other Health News
Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included a new investigation into drug prices; FDA Commissioner Scott Gottlieb, MD, provided updates on how the government shutdown is impacting FDA work; research found comorbidities impede clinical trial participation for patients with cancer.
Read more about the stories in this podcast:
Biologics, Diabetes, Cancer Drugs on House Oversight Probe List: https://www.ajmc.com/newsroom/biologics-diabetes-cancer-drugs-on-house-oversight-probe-list
HHS Medicare Drug Shift Plan Could Reduce Costs Overall but Raise Them for Some, Researchers Say: https://www.ajmc.com/newsroom/hhs-medicare-drug-shift-plan-could-reduce-costs-overall-but-raise-them-for-some-researchers-say
What We're Reading: FDA Resumes Some Inspections; Walmart Leaves CVS' PBM Networks; Flu Season: https://www.ajmc.com/newsroom/what-were-reading-fda-resumes-some-inspections-walmart-leaves-cvss-pbm-networks-flu-season
Comorbidities Impede Clinical Trial Participation Among Patients With Cancer: https://www.ajmc.com/focus-of-the-week/comorbidities-impede-clinical-trial-participation-among-patients-with-cancer
Understanding What Drives Health Information Exchange Use During Postacute Care Transitions: https://www.ajmc.com/managed-care-cast/understanding-what-drives-health-information-exchange-use-during-postacute-care-transitions
The American Journal of Managed Care—January 2019, Health IT Issue: https://www.ajmc.com/journals/issue/2019/2019-vol25-n1
6 min
January 17, 2019 Understanding What Drives Health Information Exchange Use During Postacute Care Transitions
Understanding What Drives Health Information Exchange Use During Postacute Care Transitions by Managed Care Cast
22 min
January 15, 2019 Two Years Into OCM: Successes, Challenges, and Lessons Learned
Two Years Into OCM: Successes, Challenges, and Lessons Learned by Managed Care Cast
15 min
January 12, 2019 This Week in Managed Care—Coverage From the JP Morgan Healthcare Conference and Other Health News
Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included the FDA commissioner discussing boosting drug competition; BMS offering details on its acquisition of Celgene; and cancer mortality rates declining for the 25th consecutive year.
Read more about the stories in this podcast:
FDA's Scott Gottlieb, MD, Highlights Biosimilars Initiatives in J.P. Morgan Keynote Address: https://www.centerforbiosimilars.com/conferences/jp-morgan-2019/fdas-scott-gottlieb-md-highlights-biosimilars-initiatives-in-jp-morgan-keynote-address
BMS, Celgene Discuss $74 Billion Acquisition During JP Morgan Healthcare Conference: https://www.ajmc.com/newsroom/bms-celgene-discuss-74-billion-acquisition-during-jp-morgan-healthcare-conference
Cancer Mortality Rate Drops for the 25th Consecutive Year, but Socioeconomic Gap Widens: https://www.ajmc.com/focus-of-the-week/cancer-mortality-rate-drops-for-the-25th-consecutive-year-but-socioeconomic-gap-widens
Rise of Marijuana Cries Out for Research, Regulation, Physicians Say: https://www.ajmc.com/focus-of-the-week/rise-of-marijuana-cries-out-for-research-regulation-physicians-say
CVS Health CEO Outlines How Aetna Deal Will Benefit Customers: https://www.ajmc.com/newsroom/cvs-health-ceo-outlines-how-aetna-deal-will-benefit-customers
6 min
January 08, 2019 Progress in the US With Biosimilars, but Opportunities Remain
Last year was a big year for biosimilars in the United States with the number of FDA-approved biosimilars nearly doubling and major policy and regulatory developments taking place in 2018.
Kelly Davio, senior editor of AJMC's The Center for Biosimilars, highlights recent progress, how the US market compares with Europe, and what remains to be seen.
Read more:
The Center for Biosimilars: https://www.centerforbiosimilars.com/
Stakeholders Weigh In on the Key Biosimilar Developments of 2018: https://www.centerforbiosimilars.com/news/stakeholders-weigh-in-on-the-key-biosimilar-developments-of-2018
Coherus Confirms That It Has Launched Its Pegfilgrastim Biosimilar, Udenyca: https://www.centerforbiosimilars.com/news/coherus-confirms-that-it-has-launched-its-pegfilgrastim-biosimilar-udenyca
FDA Releases Biosimilar Action Plan: https://www.centerforbiosimilars.com/news/fda-releases-biosimilar-action-plan
Pfizer Launches Epoetin Alfa Biosimilar, Retacrit, at 33.5% Discount to Reference Epogen: https://www.centerforbiosimilars.com/news/pfizer-launches-epoetin-alfa-biosimilar-retacrit-at-335-discount-to-reference-epogen
Pfizer Becomes Latest to Settle With AbbVie Over Humira: https://www.centerforbiosimilars.com/news/pfizer-becomes-latest-to-settle-with-abbvie-over-humira
14 min
January 05, 2019 This Week in Managed Care—Healthcare Impact of Government Shutdown and Other Health News
Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included a government shutdown affects healthcare; Democrats take control of the House; and AJMC® names its most influential person in healthcare.
Read more about the stories in this podcast:
How the Partial Government Shutdown Will Affect Healthcare: https://www.ajmc.com/newsroom/how-the-partial-government-shutdown-will-affect-healthcare
House Democrats Return to Power, Plan Hearings on ACA, Climate Change, Immigration Health: https://www.ajmc.com/newsroom/house-democrats-return-to-power-plan-hearings-on-aca-climate-change-immigration-health
Readers Choose the Most Influential Person in Healthcare in 2018: https://www.ajmc.com/newsroom/readers-choose-the-most-influential-person-in-healthcare-in-2018
Trump Offers Blueprint to Drive Down Prescription Drug Prices; Targets Rebates, "Middlemen": https://www.ajmc.com/newsroom/-trump-offers-blueprint-to-drive-down-prescription-drug-prices-targets-rebates-middlemen
5 Things to Know About the FDA's Biosimilar Action Plan: https://www.ajmc.com/newsroom/5-things-to-know-about-the-fdas-biosimilar-action-plan
FDA Takes Steps to Prevent Access to Flavored Tobacco Products, Ban Menthol Cigarettes: https://www.ajmc.com/newsroom/fda-takes-steps-to-prevent-access-to-flavored-tobacco-products-ban-menthol-cigarettes
What We're Reading: ACA to Remain in Place During Appeal; Cigarette Ban in Pharmacies; Judge Blocks 340B Cuts: https://www.ajmc.com/newsroom/what-were-reading-aca-to-remain-in-place-during-appeal-cigarette-ban-in-pharmacies-judge-blocks-340b-cuts
Evidence-Based Diabetes Management—December 2018: https://www.ajmc.com/journals/evidence-based-diabetes-management/2018/december-2018
5 min